Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | N/A | 3,848 | 5,988 | 7,096 | 5,833 |
| Income taxes - deferred | 362 | 410 | -1,716 | -725 | -89 |
| Accounts receivable | 9,987 | 829 | -1,860 | 1,685 | -3,259 |
| Accounts payable and accrued liabilities | N/A | N/A | -437 | -2,034 | N/A |
| Other Working Capital | 5,601 | 5,175 | 2,567 | 7,117 | 2,423 |
| Other Operating Activity | -18,895 | 7,947 | 13,488 | 8,092 | 13,010 |
| Operating Cash Flow | $-2,944 | $18,209 | $18,031 | $21,231 | $17,919 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 28 | 340 | -450 | -2,022 | -2,447 |
| Purchase Of Investment | N/A | N/A | N/A | 0 | -28 |
| Sale Of Investment | N/A | 0 | 159 | 543 | N/A |
| Other Investing Activity | 219 | 436 | 215 | 114 | 0 |
| Investing Cash Flow | $247 | $776 | $-76 | $-1,366 | $-2,475 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | 0 | -342 | -351 |
| Common Stock Repurchased | -11,314 | 0 | -1,414 | -350 | 0 |
| Dividend Paid | N/A | -3,005 | -6,304 | -8,926 | -10,777 |
| Other Financing Activity | 0 | 0 | -9 | -13 | 37 |
| Financing Cash Flow | $-11,314 | $-3,005 | $-7,727 | $-9,631 | $-11,090 |
| Exchange Rate Effect | 9 | 31 | 48 | 4 | 7 |
| Beginning Cash Position | 39,266 | 30,927 | 23,443 | 14,853 | 10,112 |
| End Cash Position | 25,264 | 46,938 | 33,718 | 25,091 | 14,472 |
| Net Cash Flow | $-14,012 | $15,980 | $10,228 | $10,234 | $4,354 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,944 | 18,209 | 18,031 | 21,231 | 17,919 |
| Capital Expenditure | N/A | -41 | -491 | -2,023 | -2,657 |
| Free Cash Flow | -2,944 | 18,168 | 17,540 | 19,207 | 15,262 |